Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nicholas J. Salgia"'
Autor:
Hedyeh Ebrahimi, Dena Battle, Nicholas J. Salgia, Zeynep B. Zengin, Nazli Dizman, Luis Meza, Cristiane D. Bergerot, Regina Barragan-Carrillo, JoAnn Hsu, Daniela Castro, Benjamin Mercier, Neal Chawla, Xiaochen Li, Abhishek Tripathi, Sandy T. Liu, Alex Chehrazi-Raffle, Ulka Vaishampayan, Michael D. Staehler, Sumanta K. Pal
Publikováno v:
Nutrients, Vol 16, Iss 11, p 1630 (2024)
Many patients diagnosed with cancer adopt dietary changes and supplement use, and a growing body of evidence suggests that such modifications can affect outcomes to cancer therapy. We sought to assess the prevalence of these practices and the surroun
Externí odkaz:
https://doaj.org/article/06e6f35dc732492abffa3b9a9898817f
Autor:
Ameish Govindarajan, Nicholas J. Salgia, Haiqing Li, Daniela V. Castro, Tamara Mirzapoiazova, Brian Armstrong, Dan Zhao, Benjamin D. Mercier, Nazli Dizman, Neal Chawla, Zeynep Zengin, Luis Meza, Nishita Tripathi, Nicolas Sayegh, Alex Chehrazi-Raffle, Abhishek Tripathi, Sumanta K. Pal
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveTo characterize and further compare the immune cell populations of the tumor microenvironment (TME) in both clear cell and papillary renal cell carcinoma (RCC) using heavy metal-labeled antibodies in a multiplexed imaging approach (imaging m
Externí odkaz:
https://doaj.org/article/151b8f04129a483a9b5f27668a5f2782
Autor:
Nicholas J. Salgia, Alexander Chehrazi‐Raffle, JoAnn Hsu, Zeynep Zengin, Sabrina Salgia, Neal S. Chawla, Luis Meza, Jasnoor Malhotra, Nazli Dizman, Ramya Muddasani, Nora Ruel, Mary Cianfrocca, Jun Gong, Sidharth Anand, Victor Chiu, James Yeh, Sumanta K. Pal
Publikováno v:
Cancer Medicine, Vol 10, Iss 16, Pp 5671-5680 (2021)
Abstract Background Tertiary cancer centers offer clinical expertise and multi‐modal approaches to treatment alongside the integration of research protocols. Nevertheless, most patients receive their cancer care at community practices. A better und
Externí odkaz:
https://doaj.org/article/3247895c6c634ff285bccc140d3b7306
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Targeted therapies have been a mainstay of the renal cell carcinoma (RCC) treatment paradigm for the better part of two decades. Multikinase inhibitors of the vascular endothelial growth factor receptor tyrosine kinases (VEGF-TKIs) comprise nearly al
Externí odkaz:
https://doaj.org/article/eafe1296caa64c6383fa1436ea805b9c
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 5, p 1508 (2020)
The treatment of metastatic renal cell carcinoma (mRCC) has rapidly evolved; however, the progress made in the field is heavily contingent upon timely and efficient accrual to clinical trials. While a substantial proportion of accrual occurs at terti
Externí odkaz:
https://doaj.org/article/bc7d5831227a48ea95d9c352fc8505c5
Autor:
Sumanta K. Pal, Neeraj Agarwal, Toni K. Choueiri, Divyam Goel, Nityam Rathi, Benjamin L. Maughan, Lesli Kiedrowski, Errol J. Philip, Neal Chawla, Jasnoor Malhotra, Sabrina Salgia, Ramya Muddasani, Alexander Chehrazi-Raffle, Luis Meza, Joann Hsu, Nazli Dizman, Nicholas J. Salgia, Caroline Weipert, Zeynep B. Zengin
Patient characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f69e25dac01722c2843f97ae2d9161
https://doi.org/10.1158/1078-0432.22480646.v1
https://doi.org/10.1158/1078-0432.22480646.v1
Autor:
Sumanta K. Pal, Neeraj Agarwal, Toni K. Choueiri, Divyam Goel, Nityam Rathi, Benjamin L. Maughan, Lesli Kiedrowski, Errol J. Philip, Neal Chawla, Jasnoor Malhotra, Sabrina Salgia, Ramya Muddasani, Alexander Chehrazi-Raffle, Luis Meza, Joann Hsu, Nazli Dizman, Nicholas J. Salgia, Caroline Weipert, Zeynep B. Zengin
Change in alterations across time points
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a356febcfa85f54de1a458cf9aafc7e8
https://doi.org/10.1158/1078-0432.22480652.v1
https://doi.org/10.1158/1078-0432.22480652.v1
Autor:
Sumanta K. Pal, Neeraj Agarwal, Toni K. Choueiri, Divyam Goel, Nityam Rathi, Benjamin L. Maughan, Lesli Kiedrowski, Errol J. Philip, Neal Chawla, Jasnoor Malhotra, Sabrina Salgia, Ramya Muddasani, Alexander Chehrazi-Raffle, Luis Meza, Joann Hsu, Nazli Dizman, Nicholas J. Salgia, Caroline Weipert, Zeynep B. Zengin
Purpose:The role of circulating cell-free tumor DNA (ctDNA) as an adjunct to tissue genomic profiling is poorly defined in metastatic renal cell carcinoma (mRCC). In this study, we aim to validate previous findings related to genomic alteration (GA)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0480fff840b8488b662c5df891a3c5f0
https://doi.org/10.1158/1078-0432.c.6530498
https://doi.org/10.1158/1078-0432.c.6530498
Publikováno v:
Cancer cell. 39(7)
A recent article in Nature Medicine explored the combination of immunotherapy with multiple distinct targeted therapies in patients with metastatic urothelial cancer, employing a biomarker-driven approach. Herein, we discuss the merits of this ambiti
Publikováno v:
Cancer Research, Statistics, and Treatment. 4:401